Comparison of ketanserin and metoprolol in the treatment of essential hypertension
- 1 February 1987
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 147 (2) , 291-296
- https://doi.org/10.1001/archinte.147.2.291
Abstract
Research from JAMA Internal Medicine — Comparison of Ketanserin and Metoprolol in the Treatment of Essential HypertensionThis publication has 8 references indexed in Scilit:
- Bioavailability and pharmacokinetics of ketanserin in elderly subjectsEuropean Journal of Clinical Pharmacology, 1985
- Ketanserin in combination with beta-adrenergic receptor blocking agents in the treatment of essential hypertension.British Journal of Clinical Pharmacology, 1984
- Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonistAmerican Journal of Obstetrics and Gynecology, 1984
- Effect of the 5‐hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin‐angiotensin system and sympatho‐adrenal function in patients with essential hypertension.British Journal of Clinical Pharmacology, 1984
- Haemodynamic and humoral responses to chronic ketanserin treatment in essential hypertension.Heart, 1984
- 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.Hypertension, 1984
- Ketanserin, a novel 5‐hydroxytryptamine antagonist: monotherapy in essential hypertension.British Journal of Clinical Pharmacology, 1983
- Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.BMJ, 1982